These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6801076)

  • 1. Characterization of the dopaminergic regulation of human prolactin-secreting cells cultured on extracellular matrix.
    Bethea CL; Ramsdell JS; Jaffe RB; Wilson CB; Weiner RI
    J Clin Endocrinol Metab; 1982 May; 54(5):893-902. PubMed ID: 6801076
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenergic and dopaminergic modulation of growth hormone and prolactin secretion in normal and tumor bearing human pituitaries in monolayer culture.
    Tallo D; Malarkey WB
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1278-84. PubMed ID: 7298804
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study of human fetal, normal adult, and somatotropic adenoma pituitary function in tissue culture.
    Marcovitz S; Goodyer CG; Guyda H; Gardiner RJ; Hardy J
    J Clin Endocrinol Metab; 1982 Jan; 54(1):6-16. PubMed ID: 6119321
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions of steroids with prolactin secretion in vitro.
    Lamberts SW
    Horm Res; 1985; 22(3):172-8. PubMed ID: 4054837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of L dopa, dopamine and CB 154 on prolactin secretion from human pituitary adenomas in vitro (proceedings) (author's transl)].
    Peillon F; Cesselin F; Zygelman N; Brandi A; Mauborgne A
    Ann Endocrinol (Paris); 1978; 39(3):255-7. PubMed ID: 718128
    [No Abstract]   [Full Text] [Related]  

  • 7. The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine.
    Israel JM; Jaquet P; Vincent JD
    Endocrinology; 1985 Oct; 117(4):1448-55. PubMed ID: 4029087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies on prolactin release and adenylate cyclase activity in human prolactin-secreting pituitary adenomas. Different sensitivity of macro- and microadenomas to dopamine and vasoactive intestinal polypeptide.
    Spada A; Nicosia S; Cortelazzi L; Pezzo G; Bassetti M; Sartorio A; Giannattasio G
    J Clin Endocrinol Metab; 1983 Jan; 56(1):1-10. PubMed ID: 6292253
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of dopamine and alpha-adrenergic receptors in human prolactin-secreting adenomas with [3H]-dihydroergocryptine.
    Ramsdell JS; Bethea CL; Jaffe RB; Wilson CB; Weiner RI
    Neuroendocrinology; 1985 Jun; 40(6):518-25. PubMed ID: 2861582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct action of opiates on bromocriptine-inhibited prolactin release by human prolactinoma cells in primary culture.
    Castanas E; Jaquet P; Gunz G; Cantau P; Giraud P
    J Clin Endocrinol Metab; 1985 Nov; 61(5):963-8. PubMed ID: 2995431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
    Jaquet P; Hassoun J; Delori P; Gunz G; Grisoli F; Weintraub BD
    J Clin Endocrinol Metab; 1984 Nov; 59(5):817-24. PubMed ID: 6480809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen enhances the sensitivity of dispersed prolactin-secreting pituitary tumor cells to dopamine and bromocriptine.
    de Quijada M; Timmermans HA; Lamberts SW; MacLeod RM
    Endocrinology; 1980 Mar; 106(3):702-6. PubMed ID: 6766385
    [No Abstract]   [Full Text] [Related]  

  • 13. Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
    Woolf PD
    Am J Physiol; 1981 Jun; 240(6):E700-4. PubMed ID: 7246736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH; Figueroa CD; Smith CM; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy in a subject with prolactin-secreting pituitary adenoma during therapy with bromocriptine].
    Passannanti G; Cardone A; Marafioti F; Alvino N
    Riv Ital Ginecol; 1980; 59 Suppl():87-91. PubMed ID: 7347889
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone secretion by dispersed cell cultures of human pituitary adenomas: effects of theophylline, thyrotropin-releasing hormone, somatostatin, and 2-bromo-alpha-ergocryptine.
    Adams EF; Brajkovich IE; Mashiter K
    J Clin Endocrinol Metab; 1979 Jul; 49(1):120-6. PubMed ID: 109461
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased responsiveness of GH3 cells to the dopaminergic inhibition of prolactin.
    Faure N; Cronin MJ; Martial JA; Weiner RI
    Endocrinology; 1980 Oct; 107(4):1022-6. PubMed ID: 6157521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin secreting pituitary adenoma: a review and study of their implications for fertility in women.
    Fode NC; Laws ER; Abboud CF; Randall RV; Kempers RD
    J Neurosurg Nurs; 1980 Dec; 12(4):210-3. PubMed ID: 6906361
    [No Abstract]   [Full Text] [Related]  

  • 20. Establishment and characterization of a new human cultured cell line from a prolactin-secreting pituitary adenoma.
    Kikuchi Y; Seki K; Momose E; Kizawa I; Oomori K; Shima K; Mukai K; Kato K
    Cancer Res; 1985 Nov; 45(11 Pt 2):5722-7. PubMed ID: 4053045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.